Association of PNPLA3 SNP rs738409 with liver density in African Americans with type 2 diabetes mellitus

Diabetes and Metabolism

Volumn 37, Issue 5, 2011, Pages 452-455

  Cox, A J ^a   Wing, M R ^a   Carr, J J ^a   Hightower, R C ^a   Smith, S C ^a   Xu, J ^a   Wagenknecht, L E ^a   Bowden, D W ^a   Freedman, B I ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

African American; Fatty liver disease; Genetics; Type 2 diabetes

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; DISEASE PREDISPOSITION; FEMALE; GENETIC RISK; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; PHENOTYPE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL;

AFRICAN AMERICANS; AGED; DIABETES MELLITUS, TYPE 2; FATTY LIVER; FEMALE; HUMANS; LIPASE; LIVER; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NORTH CAROLINA; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 81055156320     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2011.05.001     Document Type: Article

References (15)

1. Adams L.A., Harmsen S., St Sauver J.L., Charatcharoenwitthaya P., Enders F.B., Therneau T., et al. Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort study. Am J Gastroenterol 2010, 105:1567-1573.
2. Valenti L., Al-Serri A., Daly A.K., Galmozzi E., Rametta R., Dongiovanni P., et al. Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. Hepatology 2010, 51:1209-1217.
3. Romeo S., Huang-Doran I., Baroni M.G., Kotronen A. Unravelling the pathogenesis of fatty liver disease: patatin-like phospholipase domain-containing 3 protein. Curr Opin Lipidol 2010, 21:247-252.
4. Romeo S., Kozlitina J., Xing C., Pertsemlidis A., Cox D., Pennacchio L.A., et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 2008, 40:1461-1465.
5. Wagenknecht L.E., Palmer N.D., Bowden D.W., Rotter J.I., Norris J.M., Ziegler J., et al. Association of PNPLA3 with non-alcoholic fatty liver disease in a minority cohort: the Insulin Resistance Atherosclerosis Family Study. Liver Int 2011, 31:412-416.
6. Sookoian S, Pirola CJ. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology 2011;53:1883-94.
7. Steinberg G.R., Kemp B.E., Watt M.J. Adipocyte triglyceride lipase expression in human obesity. Am J Physiol Endocrinol Metab 2007, 293:E958-E964.
8. Kotronen A., Johansson L.E., Johansson L.M., Roos C., Westerbacka J., Hamsten A., et al. A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans. Diabetologia 2009, 52:1056-1060.
9. Petit J.M., Guiu B., Masson D., Duvillard L., Jooste V., Buffier P., et al. Specifically PNPLA3-mediated accumulation of liver fat in obese patients with type 2 diabetes. J Clin Endocrinol Metab 2010, 95:E430-E436.
10. Kantartzis K., Peter A., Machicao F., Machann J., Wagner S., Konigsrainer I., et al. Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene. Diabetes 2009, 58:2616-2623.
11. Divers J., Wagenknecht L.E., Bowden D.W., Carr J.J., Hightower R.C., Register T.C., et al. Ethnic differences in the relationship between pericardial adipose tissue and coronary artery calcified plaque: African-American-diabetes heart study. J Clin Endocrinol Metab 2010, 95:5382-5389.
12. Kodama Y., Ng C.S., Wu T.T., Ayers G.D., Curley S.A., Abdalla E.K., et al. Comparison of CT methods for determining the fat content of the liver. AJR Am J Roentgenol 2007, 188:1307-1312.
13. Browning J.D., Szczepaniak L.S., Dobbins R., Nuremberg P., Horton J.D., Cohen J.C., et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004, 40:1387-1395.
14. Kallwitz E.R., Guzman G., TenCate V., Vitello J., Layden-Almer J., Berkes J., et al. The histologic spectrum of liver disease in African-American, non-Hispanic white, and Hispanic obesity surgery patients. Am J Gastroenterol 2009, 104:64-69.
15. Mohanty S.R., Troy T.N., Huo D., O'Brien B.L., Jensen D.M., Hart J. Influence of ethnicity on histological differences in non-alcoholic fatty liver disease. J Hepatol 2009, 50:797-804.